Advertisement

Kodiak Sciences Inc. KOD

Set alert

Price alert · KOD

All alert types
99.18 USD -1.22 -1.22%

At close · Oct 30

99.99 +0.81 +0.82%

After hours · Oct 30, 6:32 PM ET

Bid
99.15 × 2
Ask
99.20 × 2
96.58 Day range 100.69
16.90 52-week range 100.40
YTD
+254.72%
1 year
+371.16%
Open
99.41
Prev close
100.40
Mkt cap
6.23B
Vol
568.10K
Avg vol
1.71M
EPS
-4.19
P/E
0.00
Div yield
0.00%
More statistics
Low
96.58
High
100.69
Forward P/E
-28.87
Beta
2.04
Short ratio
2.38
Inst. own
105.70%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
62.54
200-d avg
41.74
1y target
121.67

MAX chart

Chart tools
Interval

Events in this range
  • Feb 23, 2022Split: 5 for 1
  • Aug 13, 2025Earnings: -1.03; estimate -1.01; surprise -1.98%
  • Nov 13, 2025Earnings: -1.16; estimate -1.07; surprise -8.41%
  • Mar 31, 2026Earnings: -1.04; estimate -1.02; surprise -1.96%
  • May 7, 2026Earnings: -0.94; estimate -0.93; surprise -1.08%
  • Aug 12, 2026Earnings: -1.05; estimate -0.95647; surprise -9.78%
  • Aug 17, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 17, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 28, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 28, 2026Rating: UBS · Buy → Buy
  • Sep 28, 2026Rating: LifeSci Capital · Outperform → Outperform
  • Oct 12, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (116)
NameDateAgo
SMA: BullishSep 28, 20261 month ago
SMA: BullishSep 28, 20261 month ago
MACD: Buy SignalSep 28, 20261 month ago
RSI: OverboughtSep 28, 20261 month ago
SMA: BearishAug 31, 20262 months ago
SMA: BearishAug 17, 20262 months ago
MACD: Sell SignalAug 10, 20262 months ago
MACD: Buy SignalAug 3, 20262 months ago
SMA: BullishJun 29, 20264 months ago
MACD: Sell SignalMay 25, 20265 months ago
SMA: BearishMay 11, 20265 months ago
MACD: Buy SignalMar 30, 20267 months ago
SMA: BullishMar 23, 20267 months ago
RSI: OverboughtMar 23, 20267 months ago
SMA: BearishMar 2, 20268 months ago
SMA: BullishFeb 23, 20268 months ago
SMA: BearishJan 26, 20269 months ago
MACD: Sell SignalJan 26, 20269 months ago
RSI: OverboughtJan 5, 20269 months ago
RSI: OverboughtNov 10, 202511 months ago
RSI: OverboughtOct 20, 20251 year ago
RSI: OverboughtSep 22, 20251 year ago
RSI: OverboughtAug 11, 20251 year ago
RSI: OverboughtJul 21, 20251 year ago
SMA: BullishJul 14, 20251 year ago
SMA: BullishJun 30, 20251 year ago
SMA: BearishJun 16, 20251 year ago
MACD: Buy SignalJun 2, 20251 year ago
SMA: BullishApr 21, 20251 year ago
SMA: BearishFeb 17, 20251 year ago
MACD: Sell SignalFeb 3, 20251 year ago
SMA: BearishJan 13, 20251 year ago
RSI: OverboughtNov 11, 20241 year ago
SMA: BullishOct 14, 20242 years ago
SMA: BullishSep 23, 20242 years ago
MACD: Buy SignalSep 9, 20242 years ago
SMA: BearishAug 26, 20242 years ago
SMA: BullishAug 19, 20242 years ago
SMA: BearishJul 29, 20242 years ago
SMA: BullishJul 8, 20242 years ago
SMA: BearishMay 6, 20242 years ago
SMA: BullishApr 29, 20242 years ago
SMA: BearishApr 15, 20242 years ago
MACD: Sell SignalApr 15, 20242 years ago
SMA: BearishMar 25, 20242 years ago
SMA: BullishJan 8, 20242 years ago
SMA: BullishNov 13, 20232 years ago
SMA: BearishNov 6, 20232 years ago
SMA: BullishOct 30, 20233 years ago
MACD: Buy SignalOct 30, 20233 years ago
RSI: OversoldOct 23, 20233 years ago
SMA: BearishJul 24, 20233 years ago
MACD: Sell SignalJul 24, 20233 years ago
SMA: BearishJul 3, 20233 years ago
SMA: BullishMay 29, 20233 years ago
SMA: BullishMay 15, 20233 years ago
SMA: BearishFeb 6, 20233 years ago
SMA: BearishFeb 6, 20233 years ago
SMA: BullishJan 30, 20233 years ago
SMA: BearishJan 9, 20233 years ago
SMA: BullishJan 2, 20233 years ago
SMA: BullishJan 2, 20233 years ago
SMA: BearishDec 5, 20223 years ago
SMA: BullishNov 14, 20223 years ago
RSI: OversoldOct 10, 20224 years ago
SMA: BearishSep 19, 20224 years ago
SMA: BearishSep 12, 20224 years ago
SMA: BullishSep 5, 20224 years ago
SMA: BullishMay 16, 20224 years ago
MACD: Buy SignalMay 16, 20224 years ago
RSI: OversoldFeb 21, 20224 years ago
MACD: Sell SignalNov 29, 20214 years ago
SMA: BearishNov 22, 20214 years ago
SMA: BearishNov 15, 20214 years ago
SMA: BullishOct 4, 20215 years ago
SMA: BearishSep 27, 20215 years ago
SMA: BullishSep 13, 20215 years ago
MACD: Buy SignalAug 16, 20215 years ago
SMA: BullishAug 9, 20215 years ago
SMA: BearishJul 19, 20215 years ago
SMA: BullishJun 28, 20215 years ago
SMA: BearishMay 3, 20215 years ago
SMA: BullishApr 26, 20215 years ago
SMA: BearishMar 29, 20215 years ago
SMA: BearishFeb 15, 20215 years ago
MACD: Sell SignalFeb 15, 20215 years ago
SMA: BullishFeb 1, 20215 years ago
SMA: BearishJan 25, 20215 years ago
RSI: OverboughtOct 19, 20206 years ago
MACD: Buy SignalSep 21, 20206 years ago
SMA: BullishSep 14, 20206 years ago
SMA: BullishSep 7, 20206 years ago
SMA: BearishAug 31, 20206 years ago
SMA: BullishAug 24, 20206 years ago
SMA: BearishJun 22, 20206 years ago
SMA: BearishJun 22, 20206 years ago
SMA: BullishMay 4, 20206 years ago
SMA: BullishApr 6, 20206 years ago
SMA: BearishMar 30, 20206 years ago
MACD: Sell SignalFeb 17, 20206 years ago
SMA: BearishFeb 10, 20206 years ago
SMA: BullishFeb 3, 20206 years ago
SMA: BearishJan 27, 20206 years ago
RSI: OverboughtOct 14, 20197 years ago
RSI: OverboughtSep 16, 20197 years ago
SMA: BullishSep 9, 20197 years ago
MACD: Buy SignalSep 9, 20197 years ago
MACD: Sell SignalAug 19, 20197 years ago
SMA: BearishAug 5, 20197 years ago
RSI: OverboughtJul 1, 20197 years ago
RSI: OverboughtJun 10, 20197 years ago
SMA: BullishMay 13, 20197 years ago
SMA: BullishApr 8, 20197 years ago
SMA: BearishJan 21, 20197 years ago
SMA: BullishJan 7, 20197 years ago
SMA: BearishDec 10, 20187 years ago

Key statistics

Market cap
6.23B
Enterprise value
6.22B
Trailing P/E
0.00
Forward P/E
-28.87
PEG ratio
0.00
Price / sales
0.00
Price / book
101.83
EPS (TTM)
-4.19
Beta
2.04
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-58.39M
Total cash
125.90M
Total debt
52.76M
Return on equity
-368.37%
Shares outstanding
62.85M
Short % of float
21.40%
50-day average
62.54
200-day average
41.74

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 121.67 +22.7% upside
Target (low)
103.00
Target (mean)
121.67
Target (high)
145.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Nov 12, 2026

Expected Nov 12, 2026. Consensus EPS estimate -1.01.

Earnings history

Financials — quick view

All financials
KOD Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
KOD Net income — quarterly -65.64M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
KOD EPS — quarterly -1.05
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

KOD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2026Sep 30, 2026-1.06———
Aug 12, 2026Jun 30, 2026-0.95647-1.05-0.09-9.78%
May 7, 2026Mar 31, 2026-0.93-0.94-0.01-1.08%
Mar 31, 2026Dec 31, 2025-1.02-1.04-0.02-1.96%
Nov 13, 2025Sep 30, 2025-1.07-1.16-0.09-8.41%
Aug 13, 2025Jun 30, 2025-1.01-1.03-0.02-1.98%

Upgrades / downgrades

KOD analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026HC Wainwright & Co.mainBuyBuy
Sep 28, 2026LifeSci CapitalmainOutperformOutperform
Sep 28, 2026UBSmainBuyBuy
Sep 28, 2026HC Wainwright & Co.mainBuyBuy
Sep 17, 2026HC Wainwright & Co.reitBuyBuy
Aug 17, 2026HC Wainwright & Co.reitBuyBuy

About Kodiak Sciences Inc.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
kodiak.com

News

Your note

Sign in to keep a note on KOD — it syncs with the Stock Master app.

Insider holders

KOD insider holders
InsiderRelationLatest transactionDateShares held
BAKER BROS ADVISORS L.P.Beneficial Owner of more than 10% of a Class of SecurityPurchaseSep 28, 20260
BORGESON JOHN AChief Financial OfficerSaleJun 3, 2026211,930
PERLROTH VICTOR DChief Executive OfficerConversion of Exercise of derivative securitySep 24, 20263,676,060
YANG TAIYINDirectorConversion of Exercise of derivative securityOct 22, 202620,000

Institution ownership

KOD institution ownership
Holder% heldSharesValueReported
Baker Bros. Advisors, LP31.69%19,919,1861.98BJun 29, 2026
Blackrock Inc.6.58%4,135,355410.14MJun 29, 2026
Price (T.Rowe) Associates Inc5.17%3,248,611322.20MJun 29, 2026
State Street Corporation3.85%2,419,417239.96MJun 29, 2026
Goldman Sachs Group Inc3.69%2,316,014229.70MJun 29, 2026
Vanguard Capital Management LLC2.87%1,804,632178.98MJun 29, 2026

Fund ownership

KOD fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.05%1,288,755127.82MJun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.04%1,281,918127.14MSep 29, 2026
iShares Trust-iShares Russell 2000 ETF1.63%1,024,195101.58MSep 29, 2026
T. Rowe Price Health Sciences Fund, Inc.1.61%1,013,711100.54MJun 29, 2026
Artisan Partners Funds Inc.-Artisan International Small-Mid Fund0.95%595,99159.11MJun 29, 2026
T. Rowe Price New Horizons Fund, Inc.0.94%590,81658.60MJun 29, 2026
Advertisement